Back to Search Start Over

Donor cell leukemia in a patient developing 11 months after an allogeneic bone marrow transplantation for chronic myeloid leukemia

Authors :
Cengiz Yakicier
Fikret Arpaci
Türker Çetin
Şefik Güran
Murat Beyzadeoglu
Ahmet Özet
Selmin Ataergin
Source :
American Journal of Hematology
Publication Year :
2006
Publisher :
Wiley, 2006.

Abstract

A 38‐year‐old female with chronic myeloid leukemia underwent an allogeneic bone marrow transplantation from her full‐matched brother. Eleven months later, she readmitted with an acute leukemia that was shown to be of donor origin. The patient never achieved a remission even after chemotherapies with cytarabine and mitoxantrone, donor lymphocyte infusion, and second allogeneic peripheral blood stem cell transplantation. Donor cell leukemia (DCL) is sometimes misdiagnosed as relapse by clinicians and the real incidence may be higher than expected. Cytogenetic and molecular techniques may be helpful to clarify the issue of the leukemia. The current case is another case of DCL reported in the literature after an allogeneic transplant for a kind of leukemia. Am. J. Hematol. 81:370–373, 2006

Details

ISSN :
10968652 and 03618609
Volume :
81
Database :
OpenAIRE
Journal :
American Journal of Hematology
Accession number :
edsair.doi.dedup.....b16fefc0d633119fcb9e8017658ea581